drugset / Trial / NCT02455921

Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children

NCT02455921

Phase 4 Completed 200 enrolled Attikon Hospital
RandomizedParallel-groupSingle-blindScreening

Summary

The aim of this prospective randomized study is to investigate comparatively the effect of neostigmine-atropine versus sugammadex on speed and quality of recovery and on postoperative cognitive function \& behavior in children undergoing ENT surgery under general anaesthesia.

Timeline

Start
2015-06
Primary completion
2018-03
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.02 mg/kg Intravenous
Comparator Neostigmine Other / unclassified 0.05 mg/kg Intravenous
Comparator Sugammadex Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.